01 January 2008
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło, B. Gutkowska, F. HeroldAnn Transplant 2008; 13(1): 40-41 :: ID: 880205
Abstract
Background: Tacrolimus, an immunosuppressive calcineurin inhibitor, is widely used in transplantation, as well as in dermatology and invasive cardiology. This drug, first discovered as the product of Streptomyces tsukubaensis, is isolated from the whole fermentation broth of these bacteria cultivated in submerged culture strain. The aim of our research was to optimize the process of tacrolimus biosynthesis by means of submerged cultivation using liquid media containing by or waste- products of food industry. The next goal was to examine the influence of C3 effectors such as propanol, propylene glycol and propionic acid on productivity of the biosynthesis process.
Materials/Methods: The Streptomyces tsukubaensis strain (FERM BP-927) was used to investigate the relationships between the composition of the cultivation medium, the mycelial growth and tacrolimus production. Furthermore, the cultures were enriched with propanol, propylene glycol and propionic acid, used as biosynthesis precursors.
Results: The productivity of tacrolimus by the strain is proportional to the mycelial growth. The highest productivity recorded for medium composed in-part of waste products of food industry and not enriched in precursors was approximately 12 μg/mL, and thus approximates the productivity declared in Okuhara et al's US patent. The addition of the biosynthesis precursors, propanol, propylene glycol and propionic acid results in about 3-fold higher biosynthesis productivity. The highest productivity was obtained when
propylene glycol was used.
Conclusions: There is a strong correlation between the composition of the tested media and the strain productivity. Propanol, propylene glycol and propionic acid exert an inducing effect on tacrolimus biosynthesis.
Keywords: Tacrolimus, P. mirabilis, propanol
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






